DK541189A - Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af interstitiel cystitis - Google Patents

Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af interstitiel cystitis

Info

Publication number
DK541189A
DK541189A DK541189A DK541189A DK541189A DK 541189 A DK541189 A DK 541189A DK 541189 A DK541189 A DK 541189A DK 541189 A DK541189 A DK 541189A DK 541189 A DK541189 A DK 541189A
Authority
DK
Denmark
Prior art keywords
interstitial cystitis
nalmefen
naltrexon
medicine
preparation
Prior art date
Application number
DK541189A
Other languages
English (en)
Other versions
DK541189D0 (da
Inventor
Fred P Sherman
Original Assignee
Baker Cummins Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baker Cummins Pharma filed Critical Baker Cummins Pharma
Publication of DK541189D0 publication Critical patent/DK541189D0/da
Publication of DK541189A publication Critical patent/DK541189A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Threshing Machine Elements (AREA)
DK541189A 1988-11-01 1989-10-30 Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af interstitiel cystitis DK541189A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/265,575 US4877791A (en) 1988-11-01 1988-11-01 Method of treatment for interestitial cystitis

Publications (2)

Publication Number Publication Date
DK541189D0 DK541189D0 (da) 1989-10-30
DK541189A true DK541189A (da) 1990-05-02

Family

ID=23011021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK541189A DK541189A (da) 1988-11-01 1989-10-30 Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af interstitiel cystitis

Country Status (11)

Country Link
US (1) US4877791A (da)
EP (1) EP0367533B1 (da)
JP (1) JPH07556B2 (da)
AT (1) ATE102830T1 (da)
AU (1) AU623189B2 (da)
CA (1) CA2001996C (da)
DE (1) DE68913907T2 (da)
DK (1) DK541189A (da)
HK (1) HK119994A (da)
NO (1) NO894295L (da)
ZA (1) ZA897823B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases
US4994466A (en) * 1990-06-14 1991-02-19 Baker Cummins Pharmaceuticals, Inc. Method of treatment for multiple sclerosis
US5057322A (en) * 1990-08-10 1991-10-15 Baker Cummins Dermatologicals, Inc. Method of treating mast cell disease
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
DE69631525T2 (de) 1995-03-03 2004-12-16 Endo Pharmaceuticals Inc. Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
US5878750A (en) * 1996-11-14 1999-03-09 Clemens; Anton H. Method of treating the syndrome of coronary heart disease risk factors in humans
US6203813B1 (en) 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
EP1150699A4 (en) * 1999-02-01 2004-06-30 John Lezdey TREATMENT OF BLADDER AND GASTROINTESTINAL MASTO CYTOSIS
US6846831B2 (en) 2000-08-15 2005-01-25 Cpd, Llc Method of treating the syndrome of lipodystrophy
US6528520B2 (en) * 2000-08-15 2003-03-04 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
US6262062B1 (en) 2000-08-15 2001-07-17 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
WO2002081477A1 (en) * 2001-03-30 2002-10-17 Toray Industries, Inc. 7-substituted morphinane derivatives and medicinal use thereof
US7501433B2 (en) * 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US6972291B2 (en) * 2002-07-02 2005-12-06 Bernstein Richard K Method for reducing food intake
US8017622B2 (en) * 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
PT2010220T (pt) * 2006-04-03 2022-05-20 Ceva Animal Health Pty Ltd Formulações de polisulfato de pentosano estabilizado (pps)
WO2010077935A1 (en) * 2008-12-16 2010-07-08 Hill's Pet Nutrition, Inc. Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals
US20190358209A1 (en) * 2018-05-25 2019-11-28 Adamis Pharmaceuticals Corporation Drug compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51145B1 (en) * 1980-03-07 1986-10-15 Efamol Ltd Pharmaceutical and dietary compositions
WO1987002586A2 (en) * 1985-10-29 1987-05-07 Key Pharmaceuticals, Inc. Method and composition for blocking antigen-induced allergic responses
FR2609632B1 (fr) * 1987-01-21 1991-03-29 Shelly Marc Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
US4880813A (en) * 1988-07-22 1989-11-14 Baker Cummins Pharmaceuticals, Inc. Method of treatment for allergic rhinitis
US4857533A (en) * 1988-12-15 1989-08-15 Baker Cummins Pharmaceuticals, Inc. Method of treatment for autoimmune diseases

Also Published As

Publication number Publication date
CA2001996C (en) 1996-07-23
EP0367533B1 (en) 1994-03-16
JPH07556B2 (ja) 1995-01-11
ZA897823B (en) 1990-07-25
NO894295L (no) 1990-05-02
AU623189B2 (en) 1992-05-07
EP0367533A3 (en) 1991-10-02
CA2001996A1 (en) 1990-05-01
ATE102830T1 (de) 1994-04-15
JPH02188525A (ja) 1990-07-24
DK541189D0 (da) 1989-10-30
DE68913907T2 (de) 1994-06-23
HK119994A (en) 1994-11-11
DE68913907D1 (de) 1994-04-21
EP0367533A2 (en) 1990-05-09
NO894295D0 (no) 1989-10-27
US4877791A (en) 1989-10-31
AU4385089A (en) 1990-05-10

Similar Documents

Publication Publication Date Title
DK630789D0 (da) Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af autoimmune sygdomme
DK541189D0 (da) Anvendelse af nalmefen eller naltrexon til fremstilling af et laegemiddel til behandling af interstitiel cystitis
EP0377272A3 (en) Use of nalmefene or naltrexone in the manufacture of a medicament for the treatment of inflammation in an arthritic disease or associated inflammatory diseases
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
FR2550092B1 (fr) Preparation medicamenteuse solide a deux phases et son procede d'obtention
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
AU1189688A (en) Utilization of morphine antagonists in the preparation of drugs having an immunomodulator and antiviral effect, particularly for treating acquired immunodeficiency states
DK0459666T3 (da) Lægemidler mod impotens
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
ATE78687T1 (de) Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
DK0471525T3 (da) Anvendelse af en ren, narkotisk antagonist, f.eks. nalmefen, naltrexon, nalozon eller diprenorphin, til behandling af mastcellesygdom
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
IT1224250B (it) Associzione del depiprazolo con la morfina
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
IT8323253A0 (it) Preparato per la cura della crisi da astinenza nei tossicodipendenti.
ATE227573T1 (de) Orale oder intramuskuläre behandlung von pankreaskrebs durch wasserunlösliches s- camptothecin mit geschlossenem lactonring

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment
AHS Application shelved for other reasons than non-payment